000			01980 a2200589 4500
005			20250514053410.0
264		0	_c20030512
008			200305s 0 0 eng d
022			_a1535-7163
040			_aNLM _beng _cNLM
100	1		_aChen, Jun
245	0	0	_aThe apoptotic effect of HA14-1, a Bcl-2-interacting small molecular compound, requires Bax translocation and is enhanced by PK11195. _h[electronic resource]
260			_bMolecular cancer therapeutics _cOct 2002
300			_a961-7 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aAntineoplastic Agents _xpharmacology
650	0	4	_aApoptosis
650	0	4	_aBenzopyrans _xpharmacology
650	0	4	_aBlotting, Western
650	0	4	_aCaspase Inhibitors
650	0	4	_aCaspases _xmetabolism
650	0	4	_aCell Survival
650	0	4	_aCell-Free System
650	0	4	_aCells, Cultured
650	0	4	_aColoring Agents _xpharmacology
650	0	4	_aCytochrome c Group _xmetabolism
650	0	4	_aCytosol _xmetabolism
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aEnzyme Inhibitors _xpharmacology
650	0	4	_aHL-60 Cells
650	0	4	_aHumans
650	0	4	_aIn Situ Nick-End Labeling
650	0	4	_aIsoquinolines _xpharmacology
650	0	4	_aMice
650	0	4	_aMicroscopy, Fluorescence
650	0	4	_aMitochondria _xdrug effects
650	0	4	_aNitriles _xpharmacology
650	0	4	_aProtein Transport
650	0	4	_aProto-Oncogene Proteins _xmetabolism
650	0	4	_aProto-Oncogene Proteins c-bcl-2 _xmetabolism
650	0	4	_aSubcellular Fractions
650	0	4	_aTetrazolium Salts _xpharmacology
650	0	4	_aThiazoles _xpharmacology
650	0	4	_aTime Factors
650	0	4	_abcl-2-Associated X Protein
700	1		_aFreeman, Angela
700	1		_aLiu, Jihua
700	1		_aDai, Qiang
700	1		_aLee, Ruey-min
773	0		_tMolecular cancer therapeutics _gvol. 1 _gno. 12 _gp. 961-7
999			_c12285940 _d12285940